← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
176	176 DELISTED 23andMe Holding Co ME	–	–	–	–
177	MSGR 177 DELISTED Direxion mRNA ETF MSGR	–	–	–	–
178	NSTG 178 DELISTED NanoString Technologies, Inc. NSTG	–	–	–	–
179	NVTA 179 DELISTED Invitae Corporation NVTA	–	–	–	–
180	OBX 180 Obsidian Therapeutics OBX $755M	–	–	–	–
181	181 DELISTED Singular Genomics Systems, Inc. Common Stock OMIC	–	–	–	–
182	ONCS 182 DELISTED OncoSec Medical Incorporated ONCS	–	–	–	–
183	183 DELISTED Orgenesis Inc. Common Stock ORGS	–	–	–	–
184	ORTX 184 DELISTED Orchard Therapeutics plc American Depositary Shares ORTX	–	–	–	–
185	185 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	–	–	–	–
186	PTE 186 DELISTED PolarityTE, Inc. Common Stock PTE	–	–	–	–
187	RCOR 187 DELISTED Renovacor, Inc. RCOR	–	–	–	–
188	RUBY 188 DELISTED Rubius Therapeutics, Inc RUBY	–	–	–	–
189	SCPS 189 DELISTED Scopus BioPharma Inc. Common Stock SCPS	–	–	–	–
190	SCTX 190 Scribe Therapeutics Inc SCTX $393M	–	–	–	–
191	SGTX 191 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	–	–	–	–
192	SQZ 192 DELISTED SQZ Biotechnologies Company SQZ	–	–	–	–
193	193 DELISTED Telesis Bio, Inc. Common Stock TBIO	–	–	–	–
194	TCBP 194 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	–	–	–	–
195	TCRR 195 DELISTED TCR2 Therapeutics Inc. Common Stock TCRR	–	–	–	–
196	196 DELISTED Turnstone Biologics TSBX	–	–	–	–
197	197 DELISTED 2seventy bio TSVT	–	–	–	–
198	198 DELISTED Verve Therapeutics VERV	–	–	–	–
199	XDNA 199 DELISTED Strategic Trust Kelly CRISPR & Gene Editing Technology ETF XDNA	–	–	–	–